Neuroblastoma Drugs Market
The global neuroblastoma drugs market is witnessing substantial growth, with its value projected to rise from $0.7 billion in 2022 to $1.3 billion by 2032, expanding at a CAGR of 6.2%. This growth is driven by increasing R&D activities, rising incidences of neuroblastoma, and advancements in treatment options.
Comments
Post a Comment